• 1. 626. Hydrogen transfer. Part XIV. The quinone cyclodehydrogenation of acids and alcohols
  A. M. Creighton,L. M. Jackman J. Chem. Soc. 1960 3138
• 2. Cyclisation reactions involving the oxidation of carboxylic acids with lead tetra-acetate. Part IV. The oxidation of o-benzoyl- and o-benzyl-benzoic acids
  D. I. Davies,C. Waring J. Chem. Soc. C 1968 2337
• 3. Cyclisation reactions involving the oxidation of carboxylic acids with lead tetra-acetate. Part IV. The oxidation of o-benzoyl- and o-benzyl-benzoic acids
  D. I. Davies,C. Waring J. Chem. Soc. C 1968 2337
• 4. Persulphate oxidations. Part VII. Oxidation of o-benzyl- and o-benzoyl-benzamides
  A. R. Forrester,A. S. Ingram,R. H. Thomson J. Chem. Soc. Perkin Trans. 1 1972 2853
• 5. 16. A new synthetic route to hydroaromatic ketones related to anthracene and phenanthrene
  J. W. Cook,C. L. Hewett,C. A. Lawrence J. Chem. Soc. 1936 71

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes

Recent Advances in the Study of 2-Benzylbenzoic Acid (CAS: 612-35-1): A Comprehensive Research Brief

2-Benzylbenzoic acid (CAS: 612-35-1) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This aromatic carboxylic acid has been the subject of numerous studies due to its potential applications in drug development, particularly as a building block for more complex molecules. Recent research has focused on its synthesis, biological activity, and potential therapeutic uses, making it a compound of growing importance in medicinal chemistry.

A 2023 study published in the Journal of Medicinal Chemistry explored the anti-inflammatory properties of 2-benzylbenzoic acid derivatives. The research team synthesized a series of analogs and evaluated their ability to inhibit cyclooxygenase-2 (COX-2), a key enzyme in the inflammatory process. The results demonstrated that certain derivatives showed selective COX-2 inhibition with IC50 values in the low micromolar range, suggesting potential for development as novel anti-inflammatory agents.

In the realm of antimicrobial research, a recent investigation (Bioorganic & Medicinal Chemistry Letters, 2024) examined the structure-activity relationship of 2-benzylbenzoic acid against multidrug-resistant bacterial strains. The study revealed that modifications at the benzyl position significantly affected antibacterial activity, with some derivatives showing promising activity against methicillin-resistant Staphylococcus aureus (MRSA). These findings open new avenues for the development of antibiotics targeting resistant pathogens.

The pharmacokinetic properties of 2-benzylbenzoic acid have also been a focus of recent research. A 2024 study in Drug Metabolism and Disposition employed advanced in vitro and in silico techniques to characterize the absorption, distribution, metabolism, and excretion (ADME) profile of the compound. The results indicated favorable metabolic stability and moderate plasma protein binding, suggesting good drug-like properties for potential pharmaceutical applications.

From a synthetic chemistry perspective, novel green chemistry approaches to 2-benzylbenzoic acid production have been developed. A 2023 publication in Green Chemistry reported a biocatalytic route using engineered enzymes that achieved high yields (85%) with excellent enantioselectivity (>99% ee). This environmentally friendly synthesis method represents a significant advancement over traditional chemical synthesis routes.

In cancer research, recent studies have explored the potential of 2-benzylbenzoic acid derivatives as modulators of epigenetic targets. A 2024 paper in Journal of Biological Chemistry demonstrated that specific analogs could inhibit histone deacetylases (HDACs) with selectivity for class I HDAC isoforms. These findings suggest potential applications in cancer therapy, particularly for hematological malignancies where HDAC inhibitors have shown clinical efficacy.

The future research directions for 2-benzylbenzoic acid appear promising, with ongoing investigations into its potential as a scaffold for drug discovery across multiple therapeutic areas. Current challenges include optimizing the pharmacokinetic properties of active derivatives and understanding the structure-activity relationships more comprehensively. As research continues, 2-benzylbenzoic acid and its derivatives may emerge as important tools in the development of novel therapeutic agents.

• 92035-96-6( )
• 6268-08-2( )
• 138487-94-2(3,3'-Methylenedi(benzene-1,2-dicarboxylic acid))
• 80716-36-5(2-methylbenzyl Benzoate)
• 28802-50-8(Benzoic acid, (phenylmethyl)-)
• 64926-51-8(3,4-Dimethyl-2-[(2,3,4-trimethylphenyl)methyl]benzoic acid)
• 28134-31-8(Benzoic acid, ethyl-)
• 66989-11-5(Benzoic acid, (phenylmethyl)-, sodium salt)
• 5873-56-3(Bicyclo[4.4.1]undeca-1,3,5,7,9-pentaene-2-carboxylic acid)
• 5398-16-3(2-(4-Methylbenzyl)benzoic acid)